Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Peter V Jenkins"'
Autor:
Lucy de Lloyd, Peter V. Jenkins, Sarah F. Bell, Nicola J. Mutch, Julia Freyer Martins Pereira, Pilar M. Badenes, Donna James, Anouk Ridgeway, Leon Cohen, Thomas Roberts, Victoria Field, Rachel E. Collis, Peter W. Collins
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:862-879
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eeb43b94630e2e40ae00fb3da070f7e
https://doi.org/10.1016/j.jtha.2022.11.036
https://doi.org/10.1016/j.jtha.2022.11.036
Autor:
Marcela Rosas, David A Slatter, Samya G Obaji, Jason P Webber, Jorge Alvarez-Jarreta, Christopher P Thomas, Maceler Aldrovandi, Victoria J Tyrrell, Peter V Jenkins, Valerie B O'Donnell, Peter W Collins
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240189 (2020)
Tissue factor (TF) is critical for the activation of blood coagulation. TF function is regulated by the amount of externalised phosphatidylserine (PS) and phosphatidylethanolamine (PE) on the surface of the cell in which it is expressed. We investiga
Externí odkaz:
https://doaj.org/article/663339f647e04721afa1ed9dca10d61e
Autor:
Peter V. Jenkins
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34974072d0245fef895e86c88d4c0f87
http://europepmc.org/articles/PMC6462763
http://europepmc.org/articles/PMC6462763
Autor:
Peter V. Jenkins, Samya Obaji, Christopher P. Thomas, Marcela Rosas, Jason P. Webber, Jorge Alvarez-Jarreta, Peter William Collins, Valerie B. O'Donnell, David A. Slatter, Maceler Aldrovandi, Victoria J. Tyrrell
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 10, p e0240189 (2020)
PLoS ONE, Vol 15, Iss 10, p e0240189 (2020)
Tissue factor (TF) is critical for the activation of blood coagulation. TF function is regulated by the amount of externalised phosphatidylserine (PS) and phosphatidylethanolamine (PE) on the surface of the cell in which it is expressed. We investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d5a7ae454c35912c9f9b89f6b7d096
https://doi.org/10.1371/journal.pone.0240189
https://doi.org/10.1371/journal.pone.0240189
Publikováno v:
Blood. 104:256-256
Type 1 von Willebrand disease (VWD) is a heterogeneous bleeding disorder in which genetic modifying factors, including ABO blood group, contribute towards the variability in von Willebrand factor (VWF) levels. Recent findings have reported an increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c04f04c6fd11e687751c69b76a43fbf6
https://doi.org/10.1182/blood.v104.11.256.256
https://doi.org/10.1182/blood.v104.11.256.256
Autor:
Rosas, Marcela1 (AUTHOR), Slatter, David A.1 (AUTHOR), Obaji, Samya G.1 (AUTHOR), Webber, Jason P.2 (AUTHOR), Alvarez-Jarreta, Jorge1 (AUTHOR), Thomas, Christopher P.3 (AUTHOR), Aldrovandi, Maceler1 (AUTHOR), Tyrrell, Victoria J.1 (AUTHOR), Jenkins, Peter V.1 (AUTHOR), O'Donnell, Valerie B.1 (AUTHOR), Collins, Peter W.1 (AUTHOR) peter.collins@wales.nhs.uk
Publikováno v:
PLoS ONE. 10/8/2020, Vol. 15 Issue 10, p1-16. 16p.